Man Group plc lifted its position in Oscar Health, Inc. (NYSE:OSCR – Free Report) by 344.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,813,216 shares of the company’s stock after acquiring an additional 1,405,554 shares during the period. Man Group plc owned about 0.73% of Oscar Health worth $24,370,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in OSCR. JPMorgan Chase & Co. increased its position in shares of Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after acquiring an additional 8,051,379 shares in the last quarter. BIT Capital GmbH grew its position in Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after purchasing an additional 4,396,872 shares in the last quarter. Deerfield Management Company L.P. Series C grew its position in Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after purchasing an additional 3,983,325 shares in the last quarter. Hennessy Advisors Inc. grew its position in Oscar Health by 550.3% during the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after purchasing an additional 3,544,300 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC grew its position in Oscar Health by 51.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after purchasing an additional 2,151,256 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $20.08.
Oscar Health Stock Performance
Oscar Health stock opened at $16.56 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a market cap of $4.15 billion, a PE ratio of -827.59 and a beta of 1.75. The company’s 50-day moving average is $13.40 and its two-hundred day moving average is $14.65.
Oscar Health (NYSE:OSCR – Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm had revenue of $3 billion during the quarter, compared to analysts’ expectations of $2.87 billion. During the same quarter in the prior year, the company earned $0.62 EPS. The company’s revenue was up 42.2% on a year-over-year basis. Equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Insider Activity
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director now owns 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 24.39% of the stock is currently owned by company insiders.
Oscar Health Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles
- Five stocks we like better than Oscar Health
- Insider Trades May Not Tell You What You Think
- Walmart Stock Alert: Big Price Move Expected Soon
- 3 Grocery Stocks That Are Proving They Are Still Essential
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- What Does a Stock Split Mean?
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.